Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
You are reading 1 of 2 free-access articles allowed for 30 days
The remarks came when the Authority’s Board discussed correspondence from the Department of Health in relation to HIQA’s function under the General Scheme of the Human Tissue Bill at its meeting in July.
Under the Bill, it is envisaged that HIQA will become the regulator for pathology, while other regulators will be responsible for other aspects of the proposed legislation.
According to the meeting minutes, HIQA’s Director of Regulation Ms Mary Dunnion, who delivered a briefing on the issue, explained there were a number of issues to be clarified, such as the nature of inspection and enforcement powers.
“The Board expressed the view that the approach to this function is somewhat disconnected from broader legislative developments and will also generate a considerable reporting burden for services,” the minutes state.
“It was suggested that this function should be part of the licensing legislation and that this should be communicated to the DoH [Department of Health].”
A spokesperson for HIQA told the <strong><em>Medical Independent</em></strong> (<strong><em>MI</em></strong>) the Authority is still awaiting direction from the Department on these issues.
The Department of Health told <strong><em>MI</em></strong> it is proposed to bring the legislation to Cabinet for approval, along with a regulatory impact assessment, early this month.
On 11 July 2017, the Government approved the preparation of the General Scheme and Heads of a Human Tissue Bill.
It was proposed that the General Scheme will regulate the removal, retention, storage, use and disposal of human tissue from deceased persons; provide general conditions for the removal, donation and use of organs and tissues from deceased and living persons for the purposes of transplantation; and provide for an opt-out system of consent for organ donation and for an associated register.
The Human Tissue Bill will implement the key recommendation of the <em>Madden Report on Post-Mortem Practices and Procedures</em> that no hospital post-mortem examination should be carried out and no tissue retained for any purpose whatsoever without authorisation.
The HSE has not sought funding from the Department of Health to meet the community service...
The national screening advisory committee (NSAC) is progressing “the development of a methodology...
The ICGP is examining alternative pathways for entry into general practice training as part of efforts...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.